Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bataille

Showing results (291-300 of 322) with videos related to

Pageof 33
Sort By:
Blood Cancer Journal|June 11, 2013
Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cellsD Chiron, S Maïga, S Surget, et al.
Molecular and Cellular Biology|October 28, 2015
Genome-Wide Organization of GATA1 and TAL1 Determined at High ResolutionG Celine Han, Vinesh Vinayachandran, Alain R Bataille, et al.
Leukemia|February 3, 2007
Rituximab in CD20 positive multiple myelomaP Moreau, L Voillat, L Benboukher, et al.
Cancer Research|December 29, 1998
High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignanciesH Avet-Loiseau, J Y Li, T Facon, et al.
The New England Journal of Medicine|July 11, 1996
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du MyélomeM Attal, J L Harousseau, A M Stoppa, et al.
Genes, Chromosomes & Cancer|January 19, 1999
High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridizationH Avet-Loiseau, C Brigaudeau, N Morineau, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2019
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compoundsAbimael Cruz-Migoni, Peter Canning, Camilo E Quevedo, et al.
Organic Letters|September 17, 2014
trans-2-Tritylcyclohexanol as a chiral auxiliary in permanganate-mediated oxidative cyclization of 2-methylenehept-5-enoates: application to the synthesis of trans-(+)-linalool oxideAli M Al Hazmi, Nadeem S Sheikh, Carole J R Bataille, et al.
Genes, Chromosomes & Cancer|September 17, 1998
Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemiaH Avet-Loiseau, R Garand, F Gaillard, et al.
British Journal of Haematology|December 1, 1996
Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS)C Mathiot, J Y Mary, E Tartour, et al.
Pageof 33

Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
Blood Cancer Journal|June 11, 2013
Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cellsD Chiron, S Maïga, S Surget, et al.
Molecular and Cellular Biology|October 28, 2015
Genome-Wide Organization of GATA1 and TAL1 Determined at High ResolutionG Celine Han, Vinesh Vinayachandran, Alain R Bataille, et al.
Leukemia|February 3, 2007
Rituximab in CD20 positive multiple myelomaP Moreau, L Voillat, L Benboukher, et al.
Cancer Research|December 29, 1998
High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignanciesH Avet-Loiseau, J Y Li, T Facon, et al.
The New England Journal of Medicine|July 11, 1996
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du MyélomeM Attal, J L Harousseau, A M Stoppa, et al.
Genes, Chromosomes & Cancer|January 19, 1999
High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridizationH Avet-Loiseau, C Brigaudeau, N Morineau, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2019
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compoundsAbimael Cruz-Migoni, Peter Canning, Camilo E Quevedo, et al.
Organic Letters|September 17, 2014
trans-2-Tritylcyclohexanol as a chiral auxiliary in permanganate-mediated oxidative cyclization of 2-methylenehept-5-enoates: application to the synthesis of trans-(+)-linalool oxideAli M Al Hazmi, Nadeem S Sheikh, Carole J R Bataille, et al.
Genes, Chromosomes & Cancer|September 17, 1998
Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemiaH Avet-Loiseau, R Garand, F Gaillard, et al.
British Journal of Haematology|December 1, 1996
Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS)C Mathiot, J Y Mary, E Tartour, et al.
Pageof 33